MOLECULIN BIOTECH COMPLETES ENROLLMENT IN PART A OF PHASE 2/3 R/R AML MIRACLE TRIAL, KEEPING PROGRAM ON TRACK FOR Q1 2027 DATA READOUT

Reuters · 2d ago

Please log in to view news